• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

每日软组织影像引导对前列腺接受 SBRT 的患者盆腔淋巴结(PLN)照射的影响。

Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.

机构信息

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

J Appl Clin Med Phys. 2019 Jul;20(7):121-127. doi: 10.1002/acm2.12665. Epub 2019 Jun 17.

DOI:10.1002/acm2.12665
PMID:31206236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6612686/
Abstract

PURPOSE

To determine the impact of using fiducial match for daily image-guidance on pelvic lymph node (PLN) coverage for prostate cancer patients receiving stereotactic body radiation therapy (SBRT).

METHODS

Thirty patients underwent SBRT treatment to the prostate and PLN from 2014 to 2016. Each patient received either 800cGy × 5 or 500cGy × 5 to the prostate and 500cGy × 5 to the PLN. A 5 mm clinical target volume (CTV)-to-planning target volume (PTV) margin around the PLN was used for planning. Two registrations with planning computed tomography (PCT) for each of the daily cone beam CTs (CBCTs) were performed: a rigid registration to fiducials and to the bony anatomy. The average translational difference between fiducial and bony match as well as percentage of fractions with differences > 5mm were calculated. Changes in bladder and rectal volume as well as center-of-mass (COM) position from simulation parameters, and their correlation with translational difference were also evaluated. The dosimetric impact of the translational differences was calculated by shifting the plan isocenter.

RESULTS

The average translational difference between fiducial and bony match was 0.06 ± 0.82, 2.1 ± 4.1, -2.8 ± 4.3, and 5.5 ± 4.2 mm for lateral, vertical, longitudinal, and vector directions. The average change in bladder and rectal volume from simulation was -67.2 ± 163.04 cc (-12 ± 52%) and -1.6 ± 18.75 (-2 ± 30%) cc. The average change in COM of bladder from the simulation position was 0.34 ± 2.49, 4.4 ± 8.1, and -3.9 ± 7.5 mm along the LR, AP, and SI directions. The corresponding COM change for the rectum was 0.17 ± 1.9, 1.34 ± 3.5, and -0.6 ± 5.2 mm.

CONCLUSIONS

The 5 mm margin covered ~75% of fractions receiving PLN irradiation with SBRT, daily CBCT and fiducial-guided setup. The dosimetric impact on PLN coverage was significant in 19% of fractions or 25% of patients. A larger translational shift was due to variation in rectal volume and changes in COM position of the bladder and rectum. A consistent bladder positioning and/or rectum filling compared with presimulation volume were essential for adequate coverage of PLN in a hypofractionated treatment regime.

摘要

目的

确定在接受立体定向体放射治疗(SBRT)的前列腺癌患者中,使用基准点配准进行每日图像引导对骨盆淋巴结(PLN)覆盖的影响。

方法

2014 年至 2016 年期间,30 名患者接受了前列腺和 PLN 的 SBRT 治疗。每位患者均接受前列腺 800cGy×5 或 500cGy×5,PLN 接受 500cGy×5。PLN 规划时使用 5mm 临床靶区(CTV)-计划靶区(PTV)边缘。每天的锥形束 CT(CBCT)进行了两次与计划 CT(PCT)的配准:一次是基于基准点的刚性配准,一次是基于骨性解剖结构的配准。计算了基准点和骨性配准之间的平均平移差异以及差异>5mm 的分数比例。还评估了膀胱和直肠体积以及中心质量(COM)位置从模拟参数的变化,以及它们与平移差异的相关性。通过移位计划等中心点来计算平移差异的剂量学影响。

结果

基准点和骨性配准之间的平均平移差异分别为 0.06±0.82、2.1±4.1、-2.8±4.3 和 5.5±4.2mm,方向分别为横向、纵向、纵向和向量。从模拟中膀胱和直肠体积的平均变化为-67.2±163.04cc(-12±52%)和-1.6±18.75cc(-2±30%)。膀胱 COM 从模拟位置的平均变化分别为 0.34±2.49、4.4±8.1 和-3.9±7.5mm,沿 LR、AP 和 SI 方向。直肠对应的 COM 变化分别为 0.17±1.9、1.34±3.5 和-0.6±5.2mm。

结论

在接受 SBRT、每日 CBCT 和基于基准点的设置的患者中,5mm 边缘覆盖了大约 75%的 PLN 照射分数。在 19%的分数或 25%的患者中,PLN 覆盖的剂量学影响显著。较大的平移偏移是由于直肠体积的变化以及膀胱和直肠 COM 位置的变化所致。在分次治疗方案中,为了充分覆盖 PLN,需要保持膀胱的一致定位和/或直肠的充盈,使其与预模拟体积相比。

相似文献

1
Impact of daily soft-tissue image guidance to prostate on pelvic lymph node (PLN) irradiation for prostate patients receiving SBRT.每日软组织影像引导对前列腺接受 SBRT 的患者盆腔淋巴结(PLN)照射的影响。
J Appl Clin Med Phys. 2019 Jul;20(7):121-127. doi: 10.1002/acm2.12665. Epub 2019 Jun 17.
2
Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.盆腔淋巴结与前列腺配准剂量:接受立体定向体部放射治疗的高危前列腺癌患者的影响。
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):832-9. doi: 10.1016/j.ijrobp.2014.11.035.
3
Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.分析比较三维超声与锥形束 CT 在有无盆腔淋巴结照射的前列腺癌图像引导放疗中的准确性的影响因素。
Radiat Oncol. 2019 Jan 29;14(1):22. doi: 10.1186/s13014-019-1217-0.
4
PTV margin analysis for prostate patients treated with initial pelvic nodal IMRT and prostate proton boost.初始盆腔淋巴结调强放疗和前列腺质子推量治疗前列腺癌患者的 PTV 边界分析。
Phys Med Biol. 2019 Feb 8;64(4):04NT04. doi: 10.1088/1361-6560/aafd75.
5
Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.接受CBCT引导的前列腺调强放疗患者直肠和膀胱的剂量学及容积变化:基于每日CBCT剂量计算的分析
J Appl Clin Med Phys. 2016 Nov 8;17(6):107-117. doi: 10.1120/jacmp.v17i6.6207.
6
Dosimetric evaluation of three adaptive strategies for prostate cancer treatment including pelvic lymph nodes irradiation.对包括盆腔淋巴结照射在内的三种前列腺癌治疗适应性策略的剂量学评估。
Med Phys. 2015 Dec;42(12):7011-21. doi: 10.1118/1.4935529.
7
Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.前列腺癌局部放疗与盆腔放疗期间膀胱体积变化与空间剂量指标之间的关联。
Acta Oncol. 2017 Jun;56(6):884-890. doi: 10.1080/0284186X.2017.1312014. Epub 2017 Apr 12.
8
Alignment focus of daily image guidance for concurrent treatment of prostate and pelvic lymph nodes.每日影像引导同步治疗前列腺和盆腔淋巴结时的对准焦点。
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):383-9. doi: 10.1016/j.ijrobp.2013.06.003. Epub 2013 Jul 29.
9
Evaluation of margins in pelvic lymph nodes and prostate radiotherapy and the impact of bladder and rectum on prostate position.评估盆腔淋巴结和前列腺放疗中的边缘以及膀胱和直肠对前列腺位置的影响。
Cancer Radiother. 2021 Apr;25(2):161-168. doi: 10.1016/j.canrad.2020.06.033. Epub 2021 Jan 14.
10
Adaptive radiotherapy and the dosimetric impact of inter- and intrafractional motion on the planning target volume for prostate cancer patients.自适应放疗和前列腺癌患者计划靶区的分次内和分次间运动对剂量学的影响。
Strahlenther Onkol. 2020 Jul;196(7):647-656. doi: 10.1007/s00066-020-01596-x. Epub 2020 Mar 10.

引用本文的文献

1
Six-degrees-of-freedom pelvic bone monitoring on 2D kV intrafraction images to enable multi-target tracking for locally advanced prostate cancer.在二维千伏分次内图像上进行六自由度骨盆骨监测,以实现局部晚期前列腺癌的多靶点追踪。
Med Phys. 2025 Jan;52(1):77-87. doi: 10.1002/mp.17465. Epub 2024 Oct 23.
2
Impact of technological advances in treatment planning, image guidance, and treatment delivery on target margin design for prostate cancer radiotherapy: an updated review.治疗计划、图像引导和治疗传递技术进步对前列腺癌放射治疗靶区边缘设计的影响:最新综述。
Br J Radiol. 2024 Jan 23;97(1153):31-40. doi: 10.1093/bjr/tqad041.
3

本文引用的文献

1
A Phase I/II Study of Stereotactic Hypofractionated Once-weekly Radiation Therapy (SHORT) for Prostate Cancer.一项立体定向低分割每周一次放射治疗(SHORT)治疗前列腺癌的 I/II 期研究。
Clin Oncol (R Coll Radiol). 2020 Feb;32(2):e39-e45. doi: 10.1016/j.clon.2019.09.046. Epub 2019 Sep 21.
2
Impact of Lymph Node Burden on Survival of High-risk Prostate Cancer Patients Following Radical Prostatectomy and Pelvic Lymph Node Dissection.淋巴结负荷对高危前列腺癌患者根治性前列腺切除及盆腔淋巴结清扫术后生存的影响。
Front Surg. 2016 Dec 16;3:65. doi: 10.3389/fsurg.2016.00065. eCollection 2016.
3
Pelvic nodal dosing with registration to the prostate: implications for high-risk prostate cancer patients receiving stereotactic body radiation therapy.
Maintaining consistent bladder filling during external beam radiotherapy for prostate cancer.
在前列腺癌的体外放射治疗期间保持膀胱充盈一致。
Tech Innov Patient Support Radiat Oncol. 2021 Jan 30;17:1-4. doi: 10.1016/j.tipsro.2021.01.002. eCollection 2021 Mar.
盆腔淋巴结与前列腺配准剂量:接受立体定向体部放射治疗的高危前列腺癌患者的影响。
Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):832-9. doi: 10.1016/j.ijrobp.2014.11.035.
4
Intensity-modulated radiotherapy (IMRT) to prostate and pelvic nodes-is pelvic lymph node coverage adequate with fiducial-based image-guided radiotherapy?前列腺及盆腔淋巴结调强放射治疗(IMRT)——基于基准点的图像引导放射治疗对盆腔淋巴结的覆盖是否足够?
Br J Radiol. 2014 May;87(1037):20130696. doi: 10.1259/bjr.20130696. Epub 2014 Mar 20.
5
Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials.立体定向体部放疗治疗局限性前列腺癌:多机构前瞻性 II 期试验联盟的汇总分析。
Radiother Oncol. 2013 Nov;109(2):217-21. doi: 10.1016/j.radonc.2013.08.030. Epub 2013 Sep 20.
6
Later outcomes and alpha/beta estimate from hypofractionated conformal three-dimensional radiotherapy versus standard fractionation for localized prostate cancer.局部前列腺癌三维适形低分割与常规分割放疗的后期结果和α/β比值估计。
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):1200-7. doi: 10.1016/j.ijrobp.2010.12.040. Epub 2011 Apr 7.
7
Boost first, eliminate systematic error, and individualize CTV to PTV margin when treating lymph nodes in high-risk prostate cancer.在治疗高危前列腺癌的淋巴结时,首先进行增强扫描,消除系统误差,并根据个体情况确定临床靶区(CTV)到计划靶区(PTV)的边界。
Radiother Oncol. 2009 Mar;90(3):353-8. doi: 10.1016/j.radonc.2008.09.021. Epub 2008 Oct 24.
8
RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer.放射治疗肿瘤学组(RTOG)泌尿生殖系统放射肿瘤学专家就高危前列腺癌的盆腔淋巴结体积达成共识。
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):383-7. doi: 10.1016/j.ijrobp.2008.08.002. Epub 2008 Oct 22.
9
A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.一项关于使用基准标记进行图像引导调强放疗治疗包括盆腔淋巴结在内的局限性前列腺癌的研究。
Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):898-902. doi: 10.1016/j.ijrobp.2007.02.030. Epub 2007 Apr 24.
10
Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial.在放射治疗肿瘤学组9413试验中接受治疗的患者,在新辅助和同步激素治疗后进行全盆腔、“迷你盆腔”或仅前列腺外照射放疗。
Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):647-53. doi: 10.1016/j.ijrobp.2006.05.074.